Alcon’s ALC Surgical business continues to gain from its diverse portfolio and incremental innovation. Within Vision Care, the company is registering solid growth, banking on strong sales of its ...

Surgical Business Expands: In terms of the latest developments within Implantables, Alcon’s technology continues to lead the market, with every three IOLs (advanced intraocular lenses ...

TPG-backed ophthalmology specialist BVI Medical will use the investment to fund new product launches and scale its operations ...

Alcon also has a suite of advanced-technology intraocular lenses, or ATIOLs, that go beyond correcting vision issues at one distance. Although today’s global ATIOL market penetration rate by ...

Alcon, a leading name in surgical ophthalmology and contact lenses, has been recognized for ... machine and the advanced PanOptix AT-IOL are expected to further solidify the company’s market ...

Alcon, a leading name in surgical ophthalmology and contact lenses, has been recognized for its substantial ... The new phacoemulsification machine and the advanced PanOptix AT-IOL are expected to ...

ALC's performance is driven by robust demand for its innovative products, balanced geographic footprint and strong execution by the team.

Growth was fueled by strong international demand for advanced intraocular lenses, consumables, and equipment despite the U.S. market's softness and competitive pressures. Within Vision Care, Alcon is ...

Alcon projects 2025 full-year revenue between ... with international markets driving growth in advanced technology intraocular lenses (ATIOLs). Core gross margin improved by 70 basis points ...

Narrow-moat Alcon reported solid fourth-quarter earnings and ended 2024 on strong footing. Total sales of $2.5 billion were up 7.1% year over year thanks to broad-based growth across the portfolio.

Alcon Inc. ALC gains on strong market share ... Growth was fueled by strong international demand for advanced intraocular lenses, consumables, and equipment despite the U.S. market's softness ...